MS
64
7
AIV
71
9
DNB
50
-4
SLB
53
-3
DGX
39
-4
CA
36
-4
PDCO
54
-4
EXC
53
6
FLS
56
-3
LB
38
-7
DHR
56
-4
BIIB
37
7
SWKS
38
-2
IVZ
50
-3
UNP
40
-2
DE
53
8
HON
47
-12
AEP
58
2
DAL
62
-4
JBHT
50
-6
MS
64
7
AIV
71
9
DNB
50
-4
SLB
53
-3
DGX
39
-4
CA
36
-4
PDCO
54
-4
EXC
53
6
FLS
56
-3
LB
38
-7
DHR
56
-4
BIIB
37
7
SWKS
38
-2
IVZ
50
-3
UNP
40
-2
DE
53
8
HON
47
-12
AEP
58
2
DAL
62
-4
JBHT
50
-6
Financhill
Back

Rubrik Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
12

RBRK
Rubrik

Last Price:
33.35
Seasonality Move:
--
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
12
Rubrik (RBRK) is a Sell

Is Rubrik a Buy, Sell or Hold?

  • The current Rubrik [RBRK] share price is $33.29. The Score for RBRK is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • RBRK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RBRK Stock Price Chart

What is Rubrik's stock price today?

  • The Rubrik share price today is $33.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RBRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RBRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 52.19 Buy
Chaikin Money Flow: 5300691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.56 - 35.2) Sell
Bollinger Bands (100): (31.02 - 34.9) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

RBRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.99 Buy
20-day SMA: 32.83 Buy
50-day SMA: 33.45 Sell
200-day SMA: 0 Buy
8-day EMA: 32.28 Buy
20-day EMA: 32.58 Buy
50-day EMA: 33 Buy
200-day EMA: 5.94 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Rubrik Earnings Growth & RBRK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.00 per share, and an increase next year of $0.76 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Rubrik Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):